Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Implantable Barostim device improves long-term heart failure symptoms

The FDA-approved device helps regulate the heart, kidneys and vascular system by targeting sensors in a patient's carotid artery. 

Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).

TRILUMINATE update: TEER with Abbott’s TriClip device still safe, effective after 3 years

Treatment with TriClip has been consistently associated with minimal adverse events and significant improvements in quality of life. This latest update represents data from nearly 100 patients three years after implantation.  

cross market hospital mergers

Abiomed, Biosense Webster, Cerenovus now all known as Johnson & Johnson MedTech

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech. 

Thumbnail

Polaris Dawn astronauts will undergo brain MRIs upon landing

The scans will be conducted earlier than any other post-flight imaging of astronauts on record. 

Hari Naidu D, FACC, FAHA, FSCAI, director of the Hypertrophic Cardiomyopathy (HCM) National Center of Excellence, and the cardiac catheterization labs at Westchester Medical Center, and HCM patient Lindsay Davis, who is a former Miss Ohio, co-authored a new children's book on HCM.

New children's book teaches families about hypertrophic cardiomyopathy

A new book designed to educate children and their families about hypertrophic cardiomyopathy was authored by Srihari Naidu, MD, and HCM patient Lindsay Davis.

CT scans highlight impact of semaglutide on body composition

Body composition metrics derived from CT scans provide greater insight into how losing weight affects the body from a cardiometabolic perspective.

Breast arterial calcifications (BACs) identified on screening mammograms may help identify women who face a heightened risk of developing cardiovascular disease (CVD), according to a new analysis published in Clinical Imaging.

Nearly 25% of women with breast arterial calcifications on mammo develop heart disease

Specifically, women with BACs on their mammogram may be at an increased risk of atherosclerotic cardiovascular disease.

Thumbnail

Estrogen-based hormone therapy may be good for heart health

Physicians and patients alike have often wondered if these therapies are bad for the heart. It turns out, according to this new analysis, that they can be quite beneficial.